Traws Pharma, Inc. — Director's Dealing 2013

Nov 25, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Onconova Therapeutics, Inc. (ONTX)
CIK: 0001130598
Period of Report: 2013-11-22

Reporting Person: Hoffman Michael B (Director, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-11-22	Common Stock	P	100	$14.37	Acquired	4312600	Indirect
2013-11-22	Common Stock	P	4900	$14.39	Acquired	4317500	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	84530	Indirect

Footnotes

F1: These shares are held in trust for the benefit of the reporting person's descendants. The reporting person's spouse is a trustee of the trust.